M&A
Eli Lilly Infuses $1 Billion into Protomer Acquisition to Procure “Next-Gen” Insulin Products
2021-07-15
Philip Morris International Makes Second Acquisition in a Week to Push its “Beyond Nicotine” Strategy
2021-07-11
Finding Strategic Partnerships: Insider Perspectives On Biopharma Deals and Market Trends
2021-06-18
MorphoSys Partners with Royalty Pharma to Fund $1.7B Constellation Pharmaceuticals Buyout
2021-06-05
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02